The National Capacity Building (NCB) Project at the Center for Victims of Torture and The Harvard Program in Refugee Trauma are pleased to announce a special training series, “Clinical Care of Survivors of Torture, National Grand Rounds.” The National Grand Rounds are one-hour sessions and free to attend. This was the second lecture in the series of three.
Description:
This presentation will address the topic of post-acute sequelae of COVID-19 (PASC)—a constellation of symptoms described by patients after SARS-CoV-2 infection, also termed ‘Long COVID”—with a specific focus on the long-term neurocognitive impacts encountered in adult patients. I will use a case-based approach to highlight common clinical scenarios encountered in the clinical setting, describe what we know about the epidemiology and pathophysiology of these emerging post-COVID clinical phenotypes, and explore how minoritized populations may be at higher risk for PASC.
Target Audience
This program is intended for psychologists, physicians, nurses, social workers, and other staff who treat survivors of torture and refugee populations.
Objectives:
After attending this session, participants will be able to:
- Describe the spectrum of SARS-CoV-2 illness and recovery in adults
- Define the post-acute sequelae of COVID-19 (PASC), alternatively called “long COVID” or “post-COVID condition”
- Identify the neurocognitive phenotypes observed in clinical practice and any known risk factors
- Describe some best practices for the evaluation and management of patients with PASC
Presenter: George A. Alba, MD, Consultant for Minerva Biotechnologies
Dr. George Alba is a pulmonary and critical care physician at Massachusetts General Hospital and an assistant professor of medicine at Harvard Medical School. He is the co-director of the Program for Advancing Critical Care Translational Science and associate director of the Coronavirus Recovery clinic in the division of pulmonary and critical care at MGH. His research focuses on pulmonary vascular dysfunction in acute lung injury and recovery from critical illness. He is a co-investigator on several studies of the long-term consequences of COVID-19 including a co-investigator in the Boston COVID-19 Recovery Cohort, part of the national multicenter NIH RECOVER study.